Author:
Zhang Qinxiu,Ye Wenhui,Liu Ying,Niu Decao,Zhao Xin,Li Genjv,Qu Ying,Zhao Zhongxi
Subject
Pharmacology,General Medicine
Reference72 articles.
1. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management;Raghu;Am. J. Respir. Crit. Care Med.,2011
2. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS);Lynch;Am. J. Respir. Crit. Care Med.,2000
3. Incidence and prevalence of idiopathic pulmonary fibrosis;Raghu;Am. J. Respir. Crit. Care Med.,2006
4. Salvianolic acid B dry powder inhaler for the treatment of idiopathic pulmonary fibrosis;Lu;Asian J. Pharm. Sci.,2022
5. Dissecting the underlying pharmaceutical mechanism of Danggui Buxue decoction acting on idiopathic pulmonary fibrosis with network pharmacology;Zhao;TMR,2020
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献